REPORT ID 506

Global Sorafenib Sales Market Report 2019

Publish Date
2019
Pages
118
Format
Electronic (PDF)

In this report, the global Sorafenib market is valued at USD   XX million in 2019 and is expected to reach USD  XX million by the end of 2025, growing at a CAGR of  XX% between 2019 and 2025.

Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Sorafenib for these regions, from   2019 to 2025 (forecast), covering
    United States
    China
    Europe
    Japan
    Southeast Asia
    India

Global Sorafenib market competition by top manufacturers/players, with Sorafenib sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Allergan
    Alnylam Pharmaceuticals
    Acceleron Pharma
    Biocon
    Bionomics
    CASI Pharmaceuticals
    Celgene Corporation
    Enzon Pharmaceuticals
    Five Prime Therapeutics
    Fujifilm Kyowa Kirin Biologics
    Genentech
    Genexine
    Hetero Drugs
    ImClone Systems
    Intas Pharmaceuticals
    Levolta Pharmaceuticals
    Mabtech
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Capsule
    Tablet
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Hospital Pharmacy
    Retail Pharmacy
    Online Pharmacy

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

Global Sorafenib Sales Market  Report 2019
1 Sorafenib Market Overview
    1.1 Product Overview and Scope of Sorafenib
    1.2 Classification of Sorafenib by Product Category
        1.2.1 Global Sorafenib Market Size (Sales) Comparison by Type ( 2014-2024)
        1.2.2 Global Sorafenib Market Size (Sales) Market Share by Type (Product Category)  in 2018
        1.2.3 Capsule
        1.2.4 Tablet
    1.3 Global Sorafenib Market by Application/End Users
        1.3.1 Global Sorafenib Sales (Volume) and Market Share Comparison by Application ( 2014-2024)
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 Global Sorafenib Market by Region
        1.4.1 Global Sorafenib Market Size (Value) Comparison by Region ( 2014-2024)
        1.4.2 United States Sorafenib Status and Prospect ( 2014-2024)
        1.4.3 China Sorafenib Status and Prospect ( 2014-2024)
        1.4.4 Europe Sorafenib Status and Prospect ( 2014-2024)
        1.4.5 Japan Sorafenib Status and Prospect ( 2014-2024)
        1.4.6 Southeast Asia Sorafenib Status and Prospect ( 2014-2024)
        1.4.7 India Sorafenib Status and Prospect ( 2014-2024)
    1.5 Global Market Size (Value and Volume) of Sorafenib ( 2014-2024)
        1.5.1 Global Sorafenib Sales and Growth Rate ( 2014-2024)
        1.5.2 Global Sorafenib Revenue and Growth Rate ( 2014-2024)

2 Global Sorafenib Competition by Players/Suppliers, Type and Application
     2.1 Global Sorafenib Market Competition by Players/Suppliers
        2.1.1 Global Sorafenib Sales and Market Share of Key Players/Suppliers ( 2014-2019)
        2.1.2 Global Sorafenib Revenue and Share by Players/Suppliers ( 2014-2019)
    2.2 Global Sorafenib (Volume and Value) by Type
        2.2.1 Global Sorafenib Sales and Market Share by Type ( 2014-2019)
        2.2.2 Global Sorafenib Revenue and Market Share by Type ( 2014-2019)
    2.3 Global Sorafenib (Volume and Value) by Region
        2.3.1 Global Sorafenib Sales and Market Share by Region ( 2014-2019)
        2.3.2 Global Sorafenib Revenue and Market Share by Region ( 2014-2019)
    2.4 Global Sorafenib (Volume) by Application

3 United States Sorafenib (Volume, Value and Sales Price)
    3.1 United States Sorafenib Sales and Value ( 2014-2019)
        3.1.1 United States Sorafenib Sales and Growth Rate ( 2014-2019)
        3.1.2 United States Sorafenib Revenue and Growth Rate ( 2014-2019)
        3.1.3 United States Sorafenib Sales Price Trend ( 2014-2019)
    3.2 United States Sorafenib Sales Volume and Market Share by Players
    3.3 United States Sorafenib Sales Volume and Market Share by Type
    3.4 United States Sorafenib Sales Volume and Market Share by Application

4 China Sorafenib (Volume, Value and Sales Price)
    4.1 China Sorafenib Sales and Value ( 2014-2019)
        4.1.1 China Sorafenib Sales and Growth Rate ( 2014-2019)
        4.1.2 China Sorafenib Revenue and Growth Rate ( 2014-2019)
        4.1.3 China Sorafenib Sales Price Trend ( 2014-2019)
    4.2 China Sorafenib Sales Volume and Market Share by Players
    4.3 China Sorafenib Sales Volume and Market Share by Type
    4.4 China Sorafenib Sales Volume and Market Share by Application

5 Europe Sorafenib (Volume, Value and Sales Price)
    5.1 Europe Sorafenib Sales and Value ( 2014-2019)
        5.1.1 Europe Sorafenib Sales and Growth Rate ( 2014-2019)
        5.1.2 Europe Sorafenib Revenue and Growth Rate ( 2014-2019)
        5.1.3 Europe Sorafenib Sales Price Trend ( 2014-2019)
    5.2 Europe Sorafenib Sales Volume and Market Share by Players
    5.3 Europe Sorafenib Sales Volume and Market Share by Type
    5.4 Europe Sorafenib Sales Volume and Market Share by Application

6 Japan Sorafenib (Volume, Value and Sales Price)
    6.1 Japan Sorafenib Sales and Value ( 2014-2019)
        6.1.1 Japan Sorafenib Sales and Growth Rate ( 2014-2019)
        6.1.2 Japan Sorafenib Revenue and Growth Rate ( 2014-2019)
        6.1.3 Japan Sorafenib Sales Price Trend ( 2014-2019)
    6.2 Japan Sorafenib Sales Volume and Market Share by Players
    6.3 Japan Sorafenib Sales Volume and Market Share by Type
    6.4 Japan Sorafenib Sales Volume and Market Share by Application

7 Southeast Asia Sorafenib (Volume, Value and Sales Price)
    7.1 Southeast Asia Sorafenib Sales and Value ( 2014-2019)
        7.1.1 Southeast Asia Sorafenib Sales and Growth Rate ( 2014-2019)
        7.1.2 Southeast Asia Sorafenib Revenue and Growth Rate ( 2014-2019)
        7.1.3 Southeast Asia Sorafenib Sales Price Trend ( 2014-2019)
    7.2 Southeast Asia Sorafenib Sales Volume and Market Share by Players
    7.3 Southeast Asia Sorafenib Sales Volume and Market Share by Type
    7.4 Southeast Asia Sorafenib Sales Volume and Market Share by Application

8 India Sorafenib (Volume, Value and Sales Price)
    8.1 India Sorafenib Sales and Value ( 2014-2019)
        8.1.1 India Sorafenib Sales and Growth Rate ( 2014-2019)
        8.1.2 India Sorafenib Revenue and Growth Rate ( 2014-2019)
        8.1.3 India Sorafenib Sales Price Trend ( 2014-2019)
    8.2 India Sorafenib Sales Volume and Market Share by Players
    8.3 India Sorafenib Sales Volume and Market Share by Type
    8.4 India Sorafenib Sales Volume and Market Share by Application

9 Global Sorafenib Players/Suppliers Profiles and Sales Data
    9.1 Pfizer
        9.1.1 Company Basic Information, Manufacturing Base and Competitors
        9.1.2 Sorafenib Product Category, Application and Specification
            9.1.2.1 Product A
            9.1.2.2 Product B
        9.1.3 Pfizer Sorafenib Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.1.4 Main Business/Business Overview
    9.2 Allergan
        9.2.1 Company Basic Information, Manufacturing Base and Competitors
        9.2.2 Sorafenib Product Category, Application and Specification
            9.2.2.1 Product A
            9.2.2.2 Product B
        9.2.3 Allergan Sorafenib Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.2.4 Main Business/Business Overview
    9.3 Alnylam Pharmaceuticals
        9.3.1 Company Basic Information, Manufacturing Base and Competitors
        9.3.2 Sorafenib Product Category, Application and Specification
            9.3.2.1 Product A
            9.3.2.2 Product B
        9.3.3 Alnylam Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.3.4 Main Business/Business Overview
    9.4 Acceleron Pharma
        9.4.1 Company Basic Information, Manufacturing Base and Competitors
        9.4.2 Sorafenib Product Category, Application and Specification
            9.4.2.1 Product A
            9.4.2.2 Product B
        9.4.3 Acceleron Pharma Sorafenib Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.4.4 Main Business/Business Overview
    9.5 Biocon
        9.5.1 Company Basic Information, Manufacturing Base and Competitors
        9.5.2 Sorafenib Product Category, Application and Specification
            9.5.2.1 Product A
            9.5.2.2 Product B
        9.5.3 Biocon Sorafenib Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.5.4 Main Business/Business Overview
    9.6 Bionomics
        9.6.1 Company Basic Information, Manufacturing Base and Competitors
        9.6.2 Sorafenib Product Category, Application and Specification
            9.6.2.1 Product A
            9.6.2.2 Product B
        9.6.3 Bionomics Sorafenib Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.6.4 Main Business/Business Overview
    9.7 CASI Pharmaceuticals
        9.7.1 Company Basic Information, Manufacturing Base and Competitors
        9.7.2 Sorafenib Product Category, Application and Specification
            9.7.2.1 Product A
            9.7.2.2 Product B
        9.7.3 CASI Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.7.4 Main Business/Business Overview
    9.8 Celgene Corporation
        9.8.1 Company Basic Information, Manufacturing Base and Competitors
        9.8.2 Sorafenib Product Category, Application and Specification
            9.8.2.1 Product A
            9.8.2.2 Product B
        9.8.3 Celgene Corporation Sorafenib Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.8.4 Main Business/Business Overview
    9.9 Enzon Pharmaceuticals
        9.9.1 Company Basic Information, Manufacturing Base and Competitors
        9.9.2 Sorafenib Product Category, Application and Specification
            9.9.2.1 Product A
            9.9.2.2 Product B
        9.9.3 Enzon Pharmaceuticals Sorafenib Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.9.4 Main Business/Business Overview
    9.10 Five Prime Therapeutics
        9.10.1 Company Basic Information, Manufacturing Base and Competitors
        9.10.2 Sorafenib Product Category, Application and Specification
            9.10.2.1 Product A
            9.10.2.2 Product B
        9.10.3 Five Prime Therapeutics Sorafenib Sales, Revenue, Price and Gross Margin ( 2014-2019)
        9.10.4 Main Business/Business Overview
    9.11 Fujifilm Kyowa Kirin Biologics
    9.12 Genentech
    9.13 Genexine
    9.14 Hetero Drugs
    9.15 ImClone Systems
    9.16 Intas Pharmaceuticals
    9.17 Levolta Pharmaceuticals
    9.18 Mabtech

10 Sorafenib Maufacturing Cost Analysis
    10.1 Sorafenib Key Raw Materials Analysis
        10.1.1 Key Raw Materials
        10.1.2 Price Trend of Key Raw Materials
        10.1.3 Key Suppliers of Raw Materials
        10.1.4 Market Concentration Rate of Raw Materials
    10.2 Proportion of Manufacturing Cost Structure
        10.2.1 Raw Materials
        10.2.2 Labor Cost
        10.2.3 Manufacturing Process Analysis of Sorafenib
    10.3 Manufacturing Process Analysis of Sorafenib

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
    11.1 Sorafenib Industrial Chain Analysis
    11.2 Upstream Raw Materials Sourcing
    11.3 Raw Materials Sources of Sorafenib Major Manufacturers  in 2018
    11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
    12.1 Marketing Channel
        12.1.1 Direct Marketing
        12.1.2 Indirect Marketing
        12.1.3 Marketing Channel Development Trend
    12.2 Market Positioning
        12.2.1 Pricing Strategy
        12.2.2 Brand Strategy
        12.2.3 Target Client
    12.3 Distributors/Traders List

13 Market Effect Factors Analysis
    13.1 Technology Progress/Risk
        13.1.1 Substitutes Threat
        13.1.2 Technology Progress in Related Industry
    13.2 Consumer Needs/Customer Preference Change
    13.3 Economic/Political Environmental Change

14 Global Sorafenib Market Forecast ( 2019-2025)
    14.1 Global Sorafenib Sales Volume, Revenue and Price Forecast ( 2019-2025)
       14.1.1 Global Sorafenib Sales Volume and Growth Rate Forecast ( 2019-2025)
       14.1.2 Global Sorafenib Revenue and Growth Rate Forecast ( 2019-2025)
       14.1.3 Global Sorafenib Price and Trend Forecast ( 2019-2025)
    14.2 Global Sorafenib Sales Volume, Revenue and Growth Rate Forecast by Region ( 2019-2025)
       14.2.1 Global Sorafenib Sales Volume and Growth Rate Forecast by Regions ( 2019-2025)
       14.2.2 Global Sorafenib Revenue and Growth Rate Forecast by Regions ( 2019-2025)
       14.2.3 United States Sorafenib Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.4 China Sorafenib Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.5 Europe Sorafenib Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.6 Japan Sorafenib Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.7 Southeast Asia Sorafenib Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
       14.2.8 India Sorafenib Sales Volume, Revenue and Growth Rate Forecast ( 2019-2025)
    14.3 Global Sorafenib Sales Volume, Revenue and Price Forecast by Type ( 2019-2025)
       14.3.1 Global Sorafenib Sales Forecast by Type ( 2019-2025)
       14.3.2 Global Sorafenib Revenue Forecast by Type ( 2019-2025)
       14.3.3 Global Sorafenib Price Forecast by Type ( 2019-2025)
    14.4 Global Sorafenib Sales Volume Forecast by Application ( 2019-2025)

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Disclaimer